Axendia recently authored a whitepaper discussing how Biological product manufacturers seek to achieve two seemingly contradictory objectives:
- Implement tight controls over every step in the manufacturing processes to increase product yield and quality.
- Provide for a flexible manufacturing process allowing for maximum equipment reconfiguration and utilization lowering capital investments.
The paper examines technologies which can enable the transformation required to simultaneously achieve the objectives thereby reducing process variability and costs, while increasing product yields and quality.
An upcoming 3 part webinar series, based on the research findings, will address key business regulatory and technology challenges facing the Biotechnology industry, as well as provide practical and proven approaches firms can use to address them.
The topics to be covered in the series include:
- Making Life-Science from Life – The State of the Biotech Industry
- Pursuing the Golden Batch (From Data to Truth)
- The Future is Now –Manufacturing Personalized Medicines today
For more information about the webinars please visit Life-Scinece Panorama
Anonymous comments are disabled
About axendia
Axendia is a leading consulting and strategic advisory firm focused on the Life-Sciences and Healthcare markets.
Our Mission is to be the most trusted advisor to Life-Science Executives on Business, Regulatory and Technology issues.
We serve the complete Life-Science Eco-System including Life-Science Organizations, Technology & Service Providers and the Investment community.
Axendia professionals offer a unique combination of hands-on experience coupled with strategic vision. Our consultants have an average of 20 years Life-Science experience working with organizations ranging from startups to Fortune 100.
We contribute to our client’s success by helping them navigate the ever changing Business, Technological and Regulatory landscape in the Life-Sciences industry.
Let Axendia provide you the insight you need to make the right decisions in this complex and highly regulated Industry.